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Abstract 
 
(Poly)phenols are a large group of compounds, found in food, beverages, dietary supplements 
and herbal medicines. Owing to their biological activities, absorption and metabolism of the 
most abundant compounds in humans are well understood. Both the chemical structure of the 
phenolic moiety and any attached chemical groups define whether the polyphenol is absorbed 
in the small intestine, or reaches the colon and is subject to extensive catabolism by colonic 
microbiota. Untransformed substrates may be absorbed, appearing in plasma primarily as 
methylated, sulfated and glucuronidated derivatives, with in some cases the unchanged 
substrate. Many of the catabolites are well absorbed from the colon and appear in the plasma 
either similarly conjugated, or as glycine conjugates, or in some cases unchanged. 
Although many (poly)phenol catabolites have been identified in human plasma and / or urine, 
the pathways from substrate to final catabolite, and the species of bacteria and enzymes 
involved, are still scarcely reported. While it is clear that the composition of the human gut 
microbiota can be modulated in vivo by supplementation with some (poly)phenol-rich 
commodities, such modulation is definitely not an inevitable consequence of 
supplementation, it depends on the treatment, length of time and on the individual 
metabotype, and it is not clear whether the modulation is sustained when supplementation 
ceases. Some catabolites have been recorded in plasma of volunteers at concentrations similar 
to those shown to be effective in in vitro studies suggesting that some benefit may be 
achieved in vivo by diets yielding such catabolites. 
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1. (Poly)phenols covered and main classes. 
 
(Poly)phenols are a large group of compounds synthesised by plants for a variety of 
functions, such as protection against UV radiation, mechanical damage, and microbial 
infection [1, 2]. A wide variety of polyphenols are consumed as part of the normal diet [3], 
and are also present at high levels in supplements [4], and form essential components of 
many Chinese medicines [5]. A study within the European Prospective Investigation into 
Cancer and Nutrition (EPIC) using the Phenol Explorer database reported that the cohort 
studied consumed 427 different polyphenols including 94 that were consumed at a rate of >1 
g/day. The estimated total polyphenol consumption ranged from 584 mg/day by Greek 
women to 1786 mg/day for men in Aarhus-Denmark. The corresponding data for Greek men 
and for Aarhus women were 744 mg/day and 1626 mg/ day, respectively, with all data 
adjusted for age and weighted by season and weekday of dietary recall [6]. This study defined 
the major contributors to be the phenolic acids (predominantly the caffeoylquinic acids (27±
53%), also called chlorogenic acids) and flavonoids (predominantly flavanols (16±29%), 
proanthocyanidins (5±9%) and theaflavins (14±25%)) [6]. Hydroxybenzoic acids (3.3±7.4%), 
alkyl-phenols (1.6±4.)%), tyrosols (0.4±3.6%) and the glycosides of flavanones (2.6±4.0%), 
flavonols (2.8±5.1%) and flavones (0.7±1.5%) were also recorded along with smaller 
contributions from stilbenes (0.1±0.5%), lignans (0.1±0.7%) and trace amounts from several 
other subgroups. It is feasible that individuals with heavy coffee consumption might have 
greater total polyphenol intakes. Recent analyses of coffee beverage as sold in retail outlets 
can supply as much as 423 mg chlorogenic acids per cup [7]. Heavy consumers of black tea 
might also have greater total polyphenol intakes because the EPIC study did not consider 
thearubigins. Black tea theaflavins account for some 3±5% of the beverage solids compared 
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with some 17±IRUWKHH[WUHPHO\FRPSOH[WKHDUXELJLQVZKLFKFDQHTXDWHWR§PJFXS
[8-10]. It has not been possible to trace consumption data for the transformed anthocyanins 
characteristic of matured red wines, but it is clear that an extensive range is present [11, 12], 
and regular consumers of red wine might have a significant intake. It has been demonstrated 
that foods also contain a significant amount of non-extractable (poly)phenols which, 
nevertheless, are gut microbiota substrates, and these will further raise the (poly)phenol 
intake [13]. The phenol-explorer database is a useful compilation of good quality 
compositional data [3], but lacks data for the transformed anthocyanins, thearubigins and 
unextractable (poly)phenols [14]. Since phenolic acids are mostly monomeric phenols, 
flavonoids contain 2 phenolic rings, and polymerised flavonoids contain multiple phenolic 
ULQJVZHGHVLJQDWHWKHWHUP³SRO\SKHQROV´WRFRYHUWKLVJURXS[15].  
 
Flavonols, flavanones and anthocyanins exist in planta as glycosides, where the predominant 
attached sugars are glucose and rhamnose. Flavanols are present in planta mostly in their free 
forms, but can be galloylated (as in green tea) or polymerised to form proanthocyanidins, 
common components of many foods such as cocoa. Phenolic acids are usually attached to an 
organic acid, most commonly quinic acid, found at very high levels in coffee and at moderate 
levels in most fruits. Here, we will focus on the main compounds present in a normal diet, 
and only include those which have been well studied and understood. The route of absorption 
can be either through the stomach, small intestine or, if not absorbed at those sites, by the 
colon, after chemical modification by the colonic microbiota. During this process, the 
(poly)phenols become modified by various catabolic and conjugation reactions, appear in the 
blood, and are then excreted either in the urine or through the bile. Some unabsorbed 
substrate and catabolites are voided in the faeces. Recently, advances have been made 
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particularly in defining the effects of the microbiota on (poly)phenols, and how, in parallel, 
(poly)phenol-rich foods can affect the composition and activity of the microbiota. 
 
 
2. Absorption into the bloodstream 
 
Chlorogenic acid is a general term for the esters of a phenolic acid (e.g. ferulic, caffeic or 
dimethoxycinnamic acids) with quinic acid [16], and these classes are found at particularly 
high levels in coffee [17]. After reaching the small intestine, some hydrolysis of 
caffeoylquinic acid and of dimethoxycinnamoyl quinic acid occurs owing to the action of 
mammalian esterases, but the hydrolysis is relatively slow and only a proportion of the 
chlorogenic acid is hydrolysed [18]. The resulting free caffeic acid is absorbed through the 
small intestinal epithelium [19], and is rapidly sulfated, to form caffeic acid-3ƍ-O-sulfate, or 
sulfated and methylated, resulting in ferulic acid-4ƍ-O-sulfate, both with a Tmax of ~30 min 
[20]. Dimethoxycinnamic acid is rapidly and efficiently absorbed after hydrolytic removal of 
its quinic acid moiety, and circulates in plasma as the unmodified dimethoxycinnamic acid, 
again with a Tmax ~30 min [21, 22] (Fig. 1). Although dimethoxycinnamic acid is only a 
minor component of the coffee chlorogenic acids, it exhibits the highest concentration in 
plasma of all of the coffee-derived phenolic acids that are absorbed in the upper 
gastrointestinal tract. Feruloylquinic acids are not substrates for gut esterases, but a very 
small amount is absorbed intact, although the level only reaches low nM concentrations and 
this is not considered a major route of absorption and metabolism [23]. Most of the 
chlorogenic acids arrive in the colon intact. Here, the microbiota have abundant esterases for 
hydrolysing the phenolic-quinic acid linkage [24]. Released phenolic acids are readily 
converted by the microbiota to the dihydro forms, such as dihydroferulic acid and 
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dihydrocaffeic acid, and then absorbed through the colonic epithelium. Dihydroferulic, 
dihydroferulic acid-4ƍ-O-sulfate and dihydrocaffeic acid-3ƍ-O-sulfate circulate at relatively 
high concentrations [20] (Fig. 1 and 2). Some of the conjugated phenolic acids appear in the 
urine together with glycine conjugates such as feruloyl glycine. Having breakfast with coffee 
somewhat affected the timing of absorption, but not the overall amount absorbed [25], and 
non-dairy creamer, but not milk, has the same effect [26] and so the overall effect of food or 
beverages on the absorption and metabolism of chlorogenic acids appears to be minimal 
despite some reports to the contrary [27]. 
 
Hesperidin is found at high levels in citrus fruits and is the rutinoside of hesperetin 
(hesperetin-7-O-rhamnoglucoside) [28]. Intact hesperidin is not absorbed across the small 
intestine epithelium as shown by direct jejunal perfusion in humans [29] (Fig. 3). If the 
terminal rhamnose moiety is hydrolysed before consumption, the product, hesperetin-7-O-
glucoside, becomes a substrate for the brush border enzyme lactase phloridzin hydrolase. 
After hydrolysis of the attached glucose at the surface of the intestine, the resulting hesperetin 
is efficiently absorbed with a Tmax of ~30 min after direct perfusion of the pure compound 
into the jejunum [29] (Fig. 3). When hesperidin is consumed orally, hesperetin (conjugates of 
sulfate and glucuronide) appear in the plasma with a Tmax of 4-6 h. When hesperetin-7-O-
glucoside is consumed orally, the same conjugates appear in the plasma but with a much 
higher Cmax and a much shorter Tmax of ~ 30 min indicating absorption in the small intestine 
[30]. The microbiota, and not mammalian cells [31], can produce D-rhamnosidases which 
cleave the rhamnose from hesperidin [32], and this is a critical step in its absorption. Intact 
hesperidin is not absorbed passively, but hesperetin, after removal of the two sugars, is 
readily absorbed [33]. This is a clear cut example of where the attached sugars make an 
enormous and critical difference to both the site and extent of absorption. Consumption of 
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hesperidin with other foods can affect the shape of the pharmacokinetic curve [34]. The 
absorption, metabolism and excretion of hesperidin shows substantial inter-individual 
variation, but is only slightly affected by age [35]. Quercetin is found in nature attached to 
sugar moieties, such as the 3-O-JOXFRVLGHDQGƍ-O-diglucoside forms found in onions [36], 
the 3-O-rutinoside as found in tea [37] and various glycosides in apple [38]. The same 
mechanism as described above for hesperidin applies to these quercetin derivatives, where 
the glucoside is absorbed rapidly and efficiently in the small intestine, but the rutinoside is 
absorbed only after hydrolysis of the sugars by the gut microbiota in the colon, leading to less 
efficient absorption with a longer Tmax [39, 40]. The numerous conjugates of quercetin have 
been described [41, 42] and kinetic modelling has indicated that rats are not an adequate 
model to study quercetin pharmacokinetics since the pattern of conjugation is very different 
[43].  
 
(SLFDWHFKLQ%猀 -epicatechin is the most abundant form) is found in most foods as the free 
form [44], is absorbed in the small intestine, and does not need prior action of the microbiota 
for absorption [45]. It undergoes sulfation, methylation and glucuronidation with typical Tmax 
for conjugates of ~2 h [46, 47]. After both oral ingestion and direct jejunal perfusion, the EC-
ƍ-O-glucuronide conjugate is the most abundant metabolite found in plasma [48] (Fig. 4). 
Despite reported differences in analytical procedures between laboratories [47], the 
FRQVHQVXVLVWKDWí-epicatechin-ƍ-O-JOXFXURQLGHí-epicatechin-ƍ-O-VXOIDWHDQGDƍ-O-
methyl-í-epicatechin-5/7-sulfate are the predominant epicatechin metabolites in humans 
after oral consumption [47, 49]. The apparent half-life of most epicatechin conjugates is 2-4 h 
[49]. The proportion of epicatechin which is not absorbed in the small intestine will reach the 
colonic microbiota and will be converted to lower molecular weight compounds (see below) 
with no evidence for absorption of intact epicatechin in the colon.  
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Anthocyanins and proanthocyanidins are very poorly absorbed in the small intestine in their 
intact forms [50, 51]. These classes of compound are subject to extensive catabolism by the 
gut microbiota, and the products absorbed through the colon (see below). Anthocyanins are 
relatively unstable in the gastrointestinal tract, even in the conditions of the small intestine 
[52], and phenolic products from anthocyanins could arise from chemical degradation. Any 
anthocyanins which survived the small intestine would be rapidly transformed into lower 
molecular weight compounds by the colonic microbiota (see below [53, 54]). 
Proanthocyanidins are oligomeric flavanols, and there are no mammalian enzymes reported 
which have the ability to degrade the high molecular weight molecules into forms which are 
small enough to be easily absorbed in the small intestine. Only the dimer of epicatechin 
(procyanidin B2) is absorbed intact, but to a very limited extent [51]. The majority of the 
SURF\DQLGLQ%DQGRWKHUROLJRPHUVZLWKDGHJUHHRISRO\PHULVDWLRQUHDFKWKHFRORQDQG
are extensively metabolised by colonic microbiota. In rats, 80% of the microbiota-catalysed 
catabolites of radiolabelled procyandin B2 were absorbed [55]. 
 
3. Conversion of polyphenols by the gut microbiota 
 
In the last decade there have been major advances in defining the composition of the gut 
microbiota with greatly increased use of methods based on the detection and sequencing of 
16S rDNA and MALDI-TOF MS replacing conventional culture methods, but these diverse 
approaches remain complementary with more traditional methods required to determine 
microbiota functionality [56, 57]. The human gastro-intestinal tract hosts up to 100 trillion 
microbes [58], which have been assigned to well over 1000 species. The three most dominant 
bacterial phyla in the colon are the Firmicutes, Bacteroidetes, and Actinobacteria, with 
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Proteobacteria and Verrucomicrobia generally less abundant [56]. However, a detailed 
discussion of microbiota composition, reported variations therein with age [59, 60] or disease 
[61, 62], and the techniques used to determine it [56], are outside the scope of this review. 
 
With regard to microbiota-catabolism, it is convenient to divide the substrates into three 
categories. There remain some for which no data are available, the transformed anthocyanins 
(pyranoanthocyanins) of red wines, plus some minor dietary components such as algal 
phlorotannins, alkyl resorcinols, urushiols, cardanols and anacardic acids, naphthoquinones 
and anthraquinones, coumarins, isocoumarins and furanocoumarins [63]. The second group 
are those substrates associated with unique catabolites, and the third group consists of some 
structurally diverse substrates that nevertheless yield essentially the same set of catabolites, 
this latter group predominating (see Figs. 2 and 5) [64]. The unique catabolites include 4-
hydroxy-mandelic acid from p-sympatol [65], tyrosols from oleuropein and related 
compounds [66], S-equol, 5-hydroxy-equol and dihydrocinnamic acids with the aryl residue 
at C2 formed from isoflavones [67, 68], urolithins and nasutins from ellagitannins [69-71], 
diarylbutanes from lignans [32;35;36], and dihydroresveratrol from piceid and resveratrol 
[72]. The avenanthramides of oats, N-cinnamoyl conjugates of anthranilic acids, yield some 
unique catabolites, e.g. the corresponding dihydrocinnamoyl conjugates and 5-hydroxy-
anthranilic acid (2-amino-5-hydroxybenzoic acid) in addition to the much commoner 
cinnamic and dihydrocinnamic acids [73]. Many of these unique catabolites have received 
considerable attention but their precursors are minor components of the diet, albeit with some 
considerable variation between subgroups [6], depending upon whether they consume 
significant amounts of oranges [65], olive oil [74], soya beans [75, 76], nuts, pomegranates, 
strawberries and raspberries [71, 77, 78], whole grains [76], wine and peanuts [79, 80] or oats 
[81], respectively.  
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The predominant catabolites generated by the microbiota from (poly)phenols are the aromatic 
and phenolic acids with zero to three aromatic hydroxyls, or their mono- or di-methoxy 
analogues, possessing also a sidechain of one to five carbons which might bear an aliphatic 
hydroxyl [64]. These are formed from the diet predominantly from chlorogenic acids, 
flavanols, proanthocyanidins, theaflavins [6] and thearubigins [82-85], but also from many 
other minor components of the diet (Figs. 2 and 5). Human studies in vivo and gut 
microbiota-fermentation studies have demonstrated that at least some of these C6±C1 and 
possibly C6±C2 phenolic acids can be decarboxylated yielding the corresponding phenols (C6) 
or methyl-phenols (C6±C1) [84, 86-90], respectively. Phloroglucinol can also be formed from 
chalcones and dihydrochalcones [91, 92], and at least certain rumen microorganisms can 
reduce this to non-aromatic dihydrophloroglucinol [93, 94]. There are several catabolites, for 
example some mandelic and phenylhydracrylic acids, for which the origin remains uncertain. 
 
Although the microbiota-mediated transformation of dietary (poly)phenols is generally 
considered to occur in the colon, studies in vitro using ileostomy fluid establish that some 
transformation can be expected to occur in the small intestine [95]. Studies with ileostomists 
where plasma and / or urine have been analysed support this observation, but studies in which 
ileostomists are compared with volunteers having an intact colon indicate that microbiota 
catabolism in the small intestine is very much less than in the colon [23]. 
 
As a result of the catabolic reactions indicated above, the products appear in the blood and 
circulate either as free or conjugated forms. The concentration of microbiota catabolites are 
often much higher than the parent compounds. As an example, Fig. 6 shows the appearance 
of low molecular weight phenolics in the blood after consumption of a mixture of fruits. 
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Catechol and 1-methyl pyrogallol are not found in foods, but are products of catabolism by 
the gut microbiota. These are characterised by a high Tmax and a late appearance in the urine. 
As for the parent compounds, the catabolic products are also sulfated, glucuronidated and 
methylated, and although this does not necessarily account for 100% of the catabolite 
absorbed, catechol-O-sulfate is highly abundant in plasma after consumption of polyphenol-
rich foods.  
 
4. Pharmacokinetic consequences of multiple doses 
 
(Poly)phenols associated with coffee, green tea and black tea are generally consumed 
frequently during the waking day, with the result that the gut microbiota have access to 
several bolus doses for a prolonged period of time. This would predispose to a larger and 
more uniform concentration of the associated catabolites in the gastrointestinal tract and in 
plasma after absorption, but little attention has been given to how this would affect the levels 
of (poly)phenols in circulation in human intervention studies. Polyphenols undergo several 
reactions before this stage, such as deglycosylation, conjugation, ring cleavage, etc., and so 
are not amenable to classical pharmacokinetic analysis and modelling to assess the 
implications of frequent consumption. There are very few data on the human 
pharmacokinetics of intravenous doses, particularly for the gut flora catabolites, which are 
needed for such modelling. Volunteer studies of Chinese herbal preparations which contain 
preformed protocatechuic acid given intravenously have revealed a clearance half-life of ca 
10±20 minutes [96, 97].  
 
Such rapid clearance is potentially-misleading when the catabolite is not produced until the 
colon, and is then produced throughout the transit of the large bowel, resulting in absorption 
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over the same substantial time period and creating a plasma profile more closely resembling a 
prolonged intravenous infusion. There are no intravenous dosing data for the C6±C3, C6±C2 or 
C6±C5 catabolites. A study in which volunteers consumed a bolus dose of strawberry purée 
containing ellagitannins has demonstrated that the unique urolithin catabolites were still 
detected in urine 90 h later suggesting that the ellagitannin substrate may have bound to the 
mucosa and not moved with the unbound digesta [98]. It is likely that a similar phenomenon 
will occur with proanthocyanidins which also bind strongly to proteins, and possibly 
thearubigins, but because their catabolites are not unique it would be more difficult to 
demonstrate than with the ellagitannins (see Figs 2 and 5). Such binding would extend the 
period during which the microbiota could attack such substrates, potentially increasing the 
yield of catabolites and the area under the concentration±time curve for these catabolites in 
plasma. 
 
Volunteer studies of typical real world repeated consumption would, if available, circumvent 
the lack of data for intravenous dosing, but in their absence we performed a simple additive 
modelling using real data from a single dose study in order to obtain an indication of the 
potential concentrations that might be attained. This approach assumes that the rate of 
clearance from plasma does not change with dose, and would only be true if clearance was 
saturated, and thus the estimate obtained is on the high side.  
 
Figure 7 shows the data obtained for dihydroferulic acid in plasma after consumption of a 
single cup of coffee from the study of Stalmach et al [20]. We then used these data for 
estimating the consequences of human subjects consuming seven servings at two-hour 
intervals, by adding the values expected at different times using the single serving data. The 
Cmax is ~300 nM after a single serving, but reaches a steady state of ~750 nM after multiple 
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doses spaced 2 h apart, an increase of ~2.5-fold, and the total area under the curve is also 
increased 7-fold with a much longer time of exposure. It would be interesting to determine 
how multiple doses of polyphenols affect the plasma concentrations throughout the day using 
healthy volunteers, since, for example, many free-living people consume multiple cups of 
coffee at regular intervals each day. In contrast, pre-existing (poly)phenols that are absorbed 
in the stomach or duodenum (e.g. caffeoylquinic acids) will for any bolus dose be absorbed 
only during the comparatively brief residence period, and if cleared rapidly from the plasma 
will not accumulate to the same extent even if consumed at 2-hour intervals. 
 
5. Prebiotic effects 
 
There have been many studies of the potential of (poly)phenols substrates and catabolites to 
modulate the composition of the gut microbiota. These include studies using animals, in vitro 
incubations with faecal flora, and volunteer studies. Animal studies permit strategies not 
otherwise available, for example introducing a particular organism into a germ-free animal 
with suitable controls to assess its impact on the health of the gnotobiotic animal [68, 99, 
100]. Studies in which conventional animals are given an atypical, human-type diet (e.g. high 
fat, high sugar, obesogenic) supplemented with a substantial dose of a specific (poly)phenols-
rich commodity (e.g. table grapes [101] or cocoa [102]) or test substance (e.g. trans-
resveratrol [103]) have been used extensively. Often, such studies demonstrate that the test 
substance or (poly)phenol-rich commodity modulate the composition of the gut microbiota 
DQGRUDPHOLRUDWHWKHKDUPIXOHIIHFWVRIWKHWHVWDQLPDO¶VOHVVWKDQLGHDOGLHW[101-108]. 
However, as noted in an earlier review, the metabolic competence of the normal gut 
microbiota may vary markedly between species [64], and it is uncertain whether or not a 
similar effect would be achieved in humans following a realistically supplemented diet. For 
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example, after supplementation for three months in 58 volunteers with nine capsules of 
flavanol-rich green tea extract per day, equivalent to several 100 ml cups daily, there was no 
change in the gut microbiota [109]. The oral microbiota is also stable to red wine 
consumption [110]. Similarly, a study in which 25 volunteers consumed a (poly)phenol-rich 
boysenberry beverage, an apple fibre-rich beverage, or both in combination (2 × 175 ml/day), 
failed to establish any change in the gut microbiota or short chain fatty acid production [111]. 
The consumption of seven dates per day by 22 volunteers for 21 days also did not alter the 
composition of the faecal microbiota, but stool ammonia was significantly lowered [112]. 
Similarly, the consumption of 200 g per day of raspberry purée for 4 days by 10 free-living 
volunteers failed to produce a detectable change in the composition of the gut microbiota 
[53]. A 5 × 4 dietary crossover study in which 23 volunteers consumed whole apples (550 
g/day), apple pomace (22 g/day), clear or cloudy apple juice (500 ml/day) as supplements to a 
restricted diet also did not elicit any change in the gut microbiota [113]. 
 
Daily consumption of 200 ml pomegranate juice for four weeks by 12 healthy adults did not 
produce any statistically significant change in the faecal microbiota possibly because of 
considerable inter-individual variation in profile at all time points, and such inter-individual 
variation is commonplace. However, the faecal concentration of catechol was positively 
correlated with Oscillospira spp. and negatively correlated with Paraprevotella spp., whereas 
the concentration of 3-phenylpropionic acid was positively correlated with Odoribacter spp, 
and these catabolites increased significantly over the four week study [114], but such 
correlations do not establish a simple cause and effect relationship.  
In contrast, 20 volunteers consumed 1 g/day of pomegranate extract for four weeks resulting 
in significant changes in microbiota composition (increases in Bacteroidetes and 
Proteobacteria, decreases in  Firmicutes and Actinobacteria) in those volunteers at zero time 
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excreting urolithins, and those who were excreting urolithins at the end of the treatment 
period. Over the test period, there were significant increases in Veillonella spp., Serratia spp., 
Prevotella spp., Lactobacillus spp., Escherichia spp., Enterobacter spp. and Butyrivibrio spp. 
and a decline in Collinsella spp. However, six volunteers were still not excreting urolithins 
after four weeks pomegranate supplementation, but a reduction in Actinobacteria was still 
detected and there was a marginally significant decline in Bifidobacteria spp., Actinobacillus 
spp. and Thermovenabulum spp. [115]. It was noted that urolithin producers hosted at zero 
time a 33-fold greater population of Akkermansia muciniphila (phylum Actinobacteria) than 
the non-producers, and that after supplementation this differential was 47-fold [115], whereas 
Romo-Vaquero et al. were able to associate urolithin A production with Gordonibacter [116], 
an organism not detected by Li et al. These studies clearly demonstrate that there are two 
metabotypes with regard to ellagitannin catabolism ² one for whom urolithin production is 
easily inducible and the other for which induction by dietary supplementation is more 
difficult or impossible, and that certain transformations can be achieved by more than one 
genus. 
 
Moreno-Indias et al. reported that red wine (poly)phenols, given either as red wine (272 
ml/day) or dealcoholized red wine (272 ml/day) for one month, reduced the incidence of 
undesirable species (Escherichia coli and Enterobacter cloacae) and increased the incidence 
of desirable species (bifidobacteria, Lactobacillus spp., Faecalibacterium prausnitzii and 
Roseburia spp.) in 10 patients suffering from metabolic syndrome. There were some similar, 
but more modest, improvements in the faecal flora of the healthy controls. There were 
significant improvements also in systolic and diastolic blood pressure and blood glucose 
levels in the metabolic syndrome group [117]. It was noted that more 4ƍ-hydroxyphenylacetic 
acid was excreted by the healthy metabotype than the obese-diabetic metabotype after red 
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wine consumption. Although 4ƍ-hydroxyphenylacetic acid is associated with tyrosine and 
phenylalanine catabolism, it is also a gut microbiota catabolite of some dietary (poly)phenols 
and the greater excretion was ascribed provisionally to a greater proportion of 
Faecalibacterium prausnitzii, Bifidobacterium spp. and Lactobacillus spp. in the gut 
microbiota of the healthy metabotype both before and after red wine consumption [118]. This 
result confirmed earlier studies by this research group which showed increases in 
bifidobacteria and excretion of anthocyanin catabolites (syringic, p-coumaric, gallic acids and 
pyrogallol) and flavanol catabolites (hydroxyphenylvalerolactones) [119, 120]. The effect of 
consuming anthocyanin-rich blueberry-beverages on the faecal concentration of 
bifidobacteria has also been investigated, with consumption reported to produce significant 
increases in Bifidobacterium longum subsp. infantis averaged across 20 volunteers but with 
considerable inter-individual variation such that this organism sometimes declined [121]. 
 
In an 8-week placebo controlled study of 80 healthy overweight / obese volunteers with low 
intake of fruit and vegetables and a sedentary lifestyle, a subgroup of 40 where refined wheat 
products were replaced with isocaloric whole grain products, there were modest increases in 
Prevotella spp. and modest reductions in Dialister spp., Bifidobacterium spp., Blautia spp. 
and Collinsella spp., with reduction in markers of inflammation associated with whole grain 
consumption [122]. In 38 adult volunteers assessed by using an annual food frequency 
questionnaire followed by plasma and stool analysis, the regular consumers of red wine (100 
ml/day) had lower levels of Bifidobacterium spp., B. coccoides, C. leptum, and Lactobacillus 
spp., albeit with lower serum malondialdehyde than those who did not consume red wine 
[123], in contrast to the results discussed above. The markedly lower wine consumption of 
the regular drinkers is likely one factor contributing to this difference, but other diet and life-
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style factors, and differences in the particular species, strains and metabolic competence of 
bifidobacteria might also be important.  
 
Studies on volunteers must be viewed as the gold standard but they are susceptible to several 
confounding factors, such as faulty recall when food frequency questionnaires are used, or 
non-compliance when supplements are provided, and to substantial inter-individual variation. 
It has been suggested that analysis of gut microbiota catabolites in urine collected over 24-
hours, expressed relative to creatinine, can be used as a compliance monitor [124], but unless 
the supplement generates a unique catabolite there is a possibility that the consumption of for 
example coffee or tea, whether approved or not, can invalidate the compliance assessment by 
yielding the same catabolites. Even with a unique catabolite variation in yield with volunteer 
metabotype may also limit its power, especially as the yield of S-equol following soy-milk 
consumption is significantly increased when consumed with coffee [125], and Crozier et al. 
have demonstrated a more general modulating effect of cream consumed with strawberries 
and yogurt consumed with orange juice [126, 127]. Similarly consumption of coffee with 
either a high-fat or high-carbohydrate meal also delayed absorption of the gut microbiota 
catabolites [25], as did non-dairy creamer, but not milk [26]. Coupled with the noted inter-
individual variability, these factors limit the power of such studies, especially those with few 
volunteers. 
 
These limitations notwithstanding, collectively these studies demonstrate that the 
composition of the human gut microbiota can be modulated in vivo by supplementation with 
some (poly)phenol-rich commodities, but that modulation is not an inevitable consequence, 
depending at least in part on the individual metabotype. Because these supplements are 
chemically complex it is not possible to identify the substrate(s) and / or catabolite(s) 
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responsible, nor define the mechanisms responsible for any consequential changes such as 
reduction in blood pressure. It is also not possible at present to estimate the minimum 
effective dose necessary to achieve a beneficial effect in vivo, the percentage of the 
population to which it would apply, nor how long-lasting is the change in microbiota and any 
consequential benefit.  
 
That differences in customary diet can markedly influence the composition of the gut 
microbiota is strikingly illustrated by Cavalieri HWDO¶Vstudy of children in Europe and 
children in Burkina Faso. Compared with European children, those in Burkina Faso had far 
fewer Firmicutes (12% vs 51%) and far more Bacteroidetes (73% vs 27%), with a unique and 
significant content of Prevotella spp. and Xylanibacter spp. capable of degrading cellulose 
and xylans in dietary fibre. The Enterobacteriaceae (Shigella spp. and Escherichia spp) were 
significantly lower in the Burkina Faso children [128]. A comparison of their faecal and 
urinary (poly)phenols catabolites supported by in vitro faecal fermentation studies would 
make a fascinating study, as would determination of the age at which babies / young children 
acquired the (poly)phenol catabolising microbiota. In contrast to the results of this study, a 
comparison of the microbiota of urban-dwelling vegans and omnivores living in the same US 
environment revealed only modest differences, mainly in the Firmicutes (but not Prevotella 
spp.), Actinobacter and Proteobacter. There were much larger differences in the metabolome: 
The vegans had much higher plasma concentrations of 3-hydroxyhippuric acid, hippuric acid 
and catechol-O-sulfate. It was not possible to explain the small difference in microbiota 
composition associated with such substantial differences in diet, but it was suggested that if 
differences in microbiota observed in globally distinct human populations are attributable to 
differences in diet then possibly these differences take several generations to develop, or 
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possibly the young must be exposed to the different diet at an early age. Another possibility 
suggested was an environmental factor other than diet [129].   
 
Although it has long been accepted that the gut microbiota can catabolise dietary 
(poly)phenols, remarkably little attention has been paid to exactly how this is achieved. 
Controls used in model fermentations have clearly demonstrated that the catabolites produced 
by live microbiota are not observed with microbiota inactivated by chloroform suggesting 
that enzymes released from dead cells were not responsible [130, 131], and implying that 
uptake mechanisms for the test substance were available to at least some of the organisms 
present. Escherichia coli and Bifidobacterium bifidum can, under anaerobic conditions, take 
up quercetin much more efficiently than either rutin or quercetin-3-O-glucoside, and B. 
bifidum took up twice as much as E. coli. Both organisms could hydrolyse the glucoside. 
Under anaerobic conditions, E. coli mutants lacking either porins 0mpF and 0mpC or the 
efflux transporter multi-drug efflux pump AcrAB, did not differ in behaviour relative to the 
wild type [132], and so the precise uptake mechanisms remain unclear. 
 
Some dietary (poly)phenols are unstable under the conditions employed for in vitro 
fermentations, and it is important to use an uninoculated control to detect purely chemical 
transformations. In vitro studies have demonstrated that not all species of Lactobacillus and 
Bifidobacterium found in the human microbiota are resistant to (poly)phenols and / or able to 
metabolise them. For example, L. fermentum, L. acidophilus and L. vaginalis were very 
intolerant even of (+)-catechin and (±)-epicatechin, whereas L. plantarum, L. casei and L. 
bulgaricus grew best in the presence of oligomeric procyanidins. L. plantarum was able also 
to produce non-aromatic catabolites from flavanol monomers [133]. Exposure of L. 
acidophilus to rutin initiated stress response mechanisms that protected the integrity of the 
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cell boundary, modulated protein and carbohydrate metabolism, and triggered enzymes 
involved in oxidation±reduction mechanisms, indicating that adaptation is possible [134]. 
Similar studies have demonstrated that individual flavonoid aglycone substrates such as (+)-
catechin, quercetin and puerarin have significantly different effects on the microbiota 
composition. Catechin and quercetin induced significant increases in Bifidobacterium 
whereas puerarin was ineffective, and while quercetin and puerarin produced significant 
reductions in Bacteroides, catechin was much more potent [135]. Intact cell walls might 
significantly limit access of (poly)phenols-catabolising bacteria to their substrates [136], and 
Mosele et al. demonstrated that a simulated duodenal digestion that degraded pectin 
increased microbial access to many substrates [137]. It has also been demonstrated in vitro 
that the exposure to (poly)phenols modulates the ability of the microbiota to metabolise 
fructo-oligosaccharides and to generate short chain fatty acids [138, 139]. It must be 
anticipated that interactions absent from in vitro fermentations are likely in the 
gastrointestinal tract in vivo. 
 
In vitro fermentation studies of flavanol diastereoisomers have demonstrated how subtle 
differences in structure and culture media can influence the catabolism. For example, 
Adlercreutzia equolifaciens -&0UHPRYHGWKHމ-OH from (±)-epigallocatechin but did 
not produce diaryl-propanols when stimulated by hydrogen, whereas with (±)-gallocatechin, 
GLDU\OSURSDQROSURGXFWLRQGRPLQDWHGZLWKWKHމ-dehydroxylation being a secondary 
pathway. However, with Ad. equolifaciens MT4s-5, the diaryl-propanol pathway 
predominated with both substrates [140]. Ad. equolifaciens JCM 14793 was able to ring open 
(+)-catechin and (±)-epicatechin more efficiently than (±)-catechin and (+)-epicatechin. 
Access to hydrogen dramatically increased ring opening with (±)-catechin, more modestly 
increased ring opening with (+)-catechin and (±)-epicatechin, but had little effect with (+)-
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epicatechin [141]. This research group has obtained similar data for several other organisms, 
some of which are also stimulated by formate [142].  
 
One must accept that human faecal samples do not truly represent the microbiota composition 
or the metabolic competence of the gastrointestinal tract from which it was voided. Some 
species are strongly bound to the gut surface and may not be voided. Some are very sensitive 
to oxygen and may not survive transfer to the culture medium, and the medium may be less 
than ideal for some species. Examples of tightly bound microorganisms are Lactobacillus 
gasseri, L. mucosae [143] and a strain of the facultative anaerobe Bacillus subtilis isolated 
from the human gastrointestinal tract [144]. When faecal samples from 10 healthy individuals 
were applied to the in vitro catabolism of black tea or a mixture of red wine and grape juice 
FRQVLGHUDEOHYDULDWLRQZDVREVHUYHGHDFKLQGLYLGXDO¶VPLFURELRWDSURGXFLQJDGLVWLQFW
catabolite profile [89]. Interestingly, all 10 microbiota were more efficient at producing 3-މ-
hydroxyphenyl) propionic acid from red wine than from black tea, whereas the yield of 3މ -
hydroxyphenylacetic acid was much greater from black tea than red wine. While vanillic acid 
(a known peonidin catabolite) was easily produced from red wine, three microflora were able 
to produce it from black tea, which typically does not contain peonidin [89], and the 
immediate precursor is not known. In contrast, pyrogallol, a known catabolite of delphinidin 
and gallate, both of which are typically found in red wine, and 2,6-dihydroxybenzoic acid, 
were produced only from black tea. Polyphenols with a 2,6-substitution are comparatively 
rare (minor components of olives, olive oil and beer) and the immediate precursor of this 
catabolite is uncertain. Thearubigins formed either by the route described in the oxidative 
cascade hypothesis [145-148], or by peroxidase [149], are possibilities.  
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Following the development of powerful LC±MS procedures, increasingly complex mixtures 
of catabolites are reported in both in vitro fermentation and volunteer studies, and it is routine 
to propose one or more pathways to account for the multiple transformations that have been 
detected. While plausible, in the absence of detailed studies using labelled substrates and 
putative intermediates, these pathways are speculative. In view of the very large number of 
discrete species, and the recognised potential for subtle variations in metabolic competence of 
even closely related species, it is almost certain that there is more than one organism capable 
of effecting any particular transformation, and probably more than one route connecting 
substrate to any catabolite. It is routine to assume that the conversion of a C6±C5 
phenylvaleric acid proceeds via the C6±C3 phenylpropionic and C6±C2 phenylacetic 
intermediates en route to the C6±C1 benzoic acid and C6 phenol products. However, the 
absence of the C6±C4 LQWHUPHGLDWHDUJXHVDJDLQVWUHSHDWHGĮ-oxidations and might suggest 
that the C6±C2 intermediate arises from a flavonoid ring scission different from that providing 
the C6±C5 and / or C6±C3 catabolites. This inference is supported by the failure to detect the 
C6±C2 intermediate during in vitro fermentation of chlorogenic acids [150], or after dosing 
rats with dihydrocaffeic acid [151], although it is possible that its turnover is too rapid for it 
to be detected. The construction of these complex pathways is further complicated because 
VRPHWUDQVIRUPDWLRQVFDQEHPDGHDIWHUDEVRUSWLRQVXFKDVK\GURJHQDWLRQDQGȕ-oxidation. It 
is also clear from numerous studies on volunteers that both C6±C5 and C6±C3 catabolites can 
bHDEVRUEHGEXWLWLVQRWSRVVLEOHWRGHILQHZKHUHWKHȕ-oxidation occurs.  
 
The chemistry of many transformations has been reviewed [152], but some transformations 
are still poorly understood. Several mandelic acids have sometimes been considered as gut 
microbiota catabolites, but it is now recognised that 4-hydroxymandelic acid is a metabolite 
of p-sympatol (p-synephrine) and / or p-octopamine, which in dietary terms are known only 
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from citrus fruit [65, 153]. However, the rapid appearance of 4މ-hydroxymandelic acid in 
plasma (Cmax§KLQGLFDWHVWKDWWKHJXWPLFURELRWDDUHQRWQHFHVVDULO\LQYROYHG[65, 154]. 
The origin of 3މ-methoxy-4މ-hydroxymandelic acid and 4މ-hydroxymandelic acid after the 
consumption of raspberries [71], or red wine and grape juice [155], remains uncertain but 
might be a consequence of dietary (poly)phenols or associated gut microbiota catabolites 
modulating endogenous mammalian catecholamine metabolism. Catecholamines are 
endogenous precursors of mandelic acids, and the potential for such interactions are receiving 
increasing attention [156]. The precise origin of phenylhydracrylic acids also is unclear. 
Despite being strongly associated with citrus flavanone consumption, phenylhydracrylic acids 
do not seem to be produced during in vitro flavanone fermentations [15, 157], suggesting that 
they are either purely endogenous metabolites, or at least a microbial catabolite which 
requires further metabolism after absorption. Volunteer studies have established that oral 
neohesperidin dihydrochalcone [92] and hesperetin [29] yield 3މ-hydroxy-4މ-
methoxyphenylhydracrylic acid, i.e. the B-ring hydroxylation pattern is retained. This 
catabolite and 3މ-hydroxyphenylhydracrylic acid have both been reported in urine samples 
from volunteers after orange juice consumption [65, 158]. 3މ-Hydroxyphenylhydracrylic acid 
excretion increased also after consumption of a red wine-grape juice mixture [159], and 
raspberries [71], both of which lack flavanones, and there are older studies on volunteers 
which report its production from rutin [160], and after consumption of coffee [161]. Plausible 
immediate precursors are the appropriate cinnamic acid plus hydratase enzyme or 
dihydrocinnamic (3-(phenyl)propionic) acid plus P450 mono-oxygenase enzyme, but such 
precursors arise from so many substrates that many more reports of the analogous 
phenylhydracrylic acids would be expected. It has been suggested that an alternative route 
might be the formation of a phenylhydracrylic acid from a flavonoid by an unusual C-ring 
fission in which the pyran oxygen is retained on the side chain of the B-ring fragment rather 
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than on the A-ring fragment (see Fig. 8) [157]. 3މ-Hydroxy-phenylhydracrylic acid has been 
identified as a phenylalanine catabolite of incompletely characterised metronidazole-sensitive 
bacteria [162], and proposed as a urinary biomarker for a range of neurological, 
gastrointestinal, and psychiatric disorders [163], and 4މ-hydroxyphenylhydracrylic acid has 
been observed in patients with gastro-intestinal disease [164]. The definitive answer to the 
origin and significance of phenylhydracrylic acids is still lacking, but it has been shown that 
some Bacillus spp. can produce 3މ-methoxy-4މ-hydroxyphenylhydracrylic acid from ferulic 
acid [165], and it is now recognised that some distinctive strains of Bacillus are found in the 
human gut, including some B. subtilis that bind strongly to the mucosa possibly precluding 
their elimination in faeces and availability in in vitro fermentations [144, 166].  
 
 
6. Effects of catabolites 
 
In vitro cell culture studies are probably the most effective way to investigate the effects of 
gut microflora catabolites because when effects are observed there is the potential also to 
investigate the underlying mechanism(s). Choice of tissue, choice of catabolite, concentration 
and time of exposure, and choice of biomarker require careful consideration.   
 
The chosen biomarker(s) must be biologically relevant, but more importantly, those selected 
should be measurable with precision. Many biomarkers can only be quantified with a 
replicate precision in excess of 10%, or even 20%, and such imprecision makes it very 
difficult to detect small treatment-related changes in the biomarker. This constraint can be 
circumvented by increasing the catabolite concentration, but when the catabolite is used at 
even 10-fold the likely sustained plasma concentration, the relevance to real diets is 
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questionable. Certainly extrapolation to lower concentrations is unreliable as effects are likely 
to reach a threshold. 
 
Ideally, the range of catabolite concentration should centre on plasma / tissue concentrations 
associated with real-world diets perceived as being beneficial to health. Such data for tissues 
are conspicuous by their absence but plasma Cmax values for metabolites absorbed in the 
proximal gastrointestinal tract rarely exceed a transient 50 nM for a single bolus dose (unless 
supplemented) [25, 167-169] although 3ƍ,4ƍ-dimethoxycinnamic acid (ca  0.6 µM after ca two 
cups of coffee) [170] and 4-hydroxybenzoic acid (2.5 µM after 300 g fresh strawberries) [22] 
are notable exceptions. In contrast, as discussed above, for those catabolites derived from 
multiple substrates, and especially those associated with commodities consumed repeatedly at 
short intervals during the day, a higher Cmax is to be expected, in some cases exceeding 1 µM. 
More importantly, a concentration of at least 0.5 Cmax will be maintained for a considerable 
period, possibly overnight. Concentrations in human faecal water can be much higher [171], 
exposing the gut microbiota and the colonic mucosa to individual catabolites at 
concentrations in excess of 10 µM. Because multiple catabolites are present simultaneously, 
the total exposure in the plasma might realistically be some 2±3-fold higher and in the colon 
in excess of 1 mM. The relatively long-term exposure, possibly every day, give these 
catabolites a real potential to exert biological effects in vivo. 
 
Data for a range of C6±C1, C6±C2, and C6±C3 phenolic acids are presented in Table 1, so far as 
possible comparing concentrations achieved in plasma and the colon following 
unsupplemented diets with data for biological effects observed in vitro. None of these studies 
observed any effect below 0.1 µM ² indeed none even investigated a lower concentration. A 
simple comparison of plasma and colon concentrations with concentrations shown to be 
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effective in vitro suggests that there is potential for protocatechuic acid, vanillic acid, gallic 
acid and 3ƍ,4ƍ-dihydroxyphenylacetic acid to exert modest effects in vivo in at least some 
volunteers on real-ZRUOGGLHWVމ-+\GUR[\SKHQ\OSURSLRQLFDFLGމމ-
GLK\GUR[\SKHQ\OSURSLRQLFDQGމ-methoxy-މ-hydroxyphenylpropionic might also achieve 
sufficient concentrations following repeated consumption of coffee or tea. Note, however, 
that at least some of these catabolites, including protocatechuic and vanillic acids, bind to 
human serum albumin [172], and this might reduce their potency in vivo. 
 
There has been limited investigation of mixtures of (poly)phenolic catabolites. In one study 
there was no evidence of any additive effect [173], but in another study a mixture of 4-
hydroxybenzoic acid, protocatechuic acid and vanillic acid (albeit each at 0.33 µM) was more 
effective than any component alone at the same concentration [174], suggesting that there is 
some synergy rather than merely an additive effect. There is clearly a potential for some 
carefully-targeted studies seeking synergy, and these should not be restricted to (poly)phenol 
mixtures but embrace other classes of phytonutrients, and a need for further data on plasma 
and tissue catabolite concentrations in free-living volunteers, preferably in association with 
their dietary history. The development of biomarker assays, and the requisite reagents, to 
facilitate the generation of more precise replicate data would be a distinct advantage.
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7. Summary, conclusions and recommendations for future research 
 
The colonic microbiota transform a very complex range of (poly)phenol substrates with 
coffee chlorogenic acids, black tea theaflavins and thearubigins often dominating, with 
substantial contributions from proanthocyanidins and flavanols, flavonols, flavanones and 
anthocyanin glycosides, and unextractable (poly)phenols, from many fruit and vegetables. 
These transformations can be extensive, and while some microbial catabolites are substrate-
specific (e.g. equol, urolithins and nasutins, mammalian lignans, hydroxyanthranilic acid), 
certain catabolites are common to many of the major substrates, implying that the spectrum 
of catabolites produced is less complex and qualitatively less variable than the spectrum of 
substrates consumed. The catabolites most likely to dominate are the C6 phenols, C6±C1, C6±
C2 and C6±C3 dihydro acids derived from chlorogenic acids/cinnamates, and most flavonoids 
including black tea thearubigins and theaflavins (see Figs. 2 and 5).  
 
There is growing evidence from in vitro and intervention studies that some of these 
catabolites are biologically active, and that, along with untransformed substrates, may 
function as prebiotics capable of modulating the human gut microbiota composition. In 
addition, some catabolites after absorption may have further beneficial effects provided that 
sufficient concentrations are achieved for a sufficient time in the relevant tissue(s). 
Consumption of multiple doses, such as regular coffee and tea drinking throughout the day, 
have the potential to increase the plasma concentration of catabolites, especially for those 
derived from microbial action. 
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Future investigations must address the minimum effective dose of potentially prebiotic 
substrates, determine what percentage of the population are susceptible, whether 
susceptibility can be induced, and how long any associated benefits persist, especially if the 
supplementation is subsequently curtailed. There is also a pressing need for investigation of 
free-living volunteers who regularly consume (poly)phenol-rich beverages at frequent 
intervals to better define the circulating catabolite profiles after consumption of multiple 
doses. The answers to these are crucial if we are to understand and fully exploit the effect of 
(poly)phenol consumption on human health. 
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Figure legends 
 
Figure 1. Appearance of phenolic acids in plasma after consumption of chlorogenic acids 
from coffee. Healthy volunteers (n=11) drank 3.4 g instant coffee a 200 ml cup of coffee, or 
4.0 g of instant coffee in 400 ml (n=8) for the dimethoxycinnamic acid estimation. 
Dimethoxycinnamic acid (ƇGLK\GURIHUXOLFDFLGƍ-O-VXOIDWHŸGLK\GURIHUXOLFDFLG¨
IHUXOLFDFLGƍ-O-sulfate (Ɣ), 5-feruloylquinic acid (Ŷ), dihydrocaffeic acid-ƍ-O-VXOIDWHƑ
caffeic acid-ƍ-O-VXOIDWHż5HGUDZQXVLQJGDWDIURP[20] and [22].         
 
Figure 2: Diagrammatic illustration of the conversion of three classes of dominant dietary 
(poly)phenols to a series of common catabolites 
 
Figure 3. Appearance of hesperetin in plasma after consumption of hesperetin 7-O-glucoside 
or 7-O-rhamnoside. Oral consumption (Panel A) or direct jejunal perfusion (Panel B) of 
hesperidin (hesperetin-7-O-rhamnoside), and oral consumption (Panel C) or direct jejunal 
perfusion (Panel D) of hesperetin-7-O-glucoside. Hesperetin after absorption is found as 
glucuronidated and sulfated conjugates, but here enzymic deconjugation was used to convert 
them back to hesperetin aglycone. Redrawn using data from [30] and [29]. 
 
Figure 4. Appearance of epicatechin conjugates in plasma. Upper panel: after oral 
administration of chocolate containing 79 mg of epicatechin; n=5. Lower panel: after direct 
jejunal perfusion of 50 mg pure epicatechin; n=6; EC-ƍ-O-JOF$Ŷ(&-ƍ-O-VXOIDWHƔ0H-
EC-5-O-VXOIDWHŸ5HGUDZQIURP[48, 49]. Note that the y axes are different scales. 
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Figure 5: Specimen structures for two classes of dominant dietary (poly)phenol substrates 
that are not absorbed unchanged. The initial catabolic steps are not precisely known but lead 
to products similar to those shown in Fig. 2 for (±)-epicatechin. 
 
Figure 6. Appearance of microbial metabolites in the plasma and urine from volunteers 
(n=22) after consumption of mixed berry fruits. Top panel: Plasma catechol-O-VXOIDWHŶDQG
1-methyl-pyrogallol-O-VXOIDWHƔ/RZHUSDQHO8ULQDU\FDWHFKRO-O-sulfate. Redrawn from 
[87] and [86]. *, p < 0.05; **, p < 0.01 relative to time zero. Relative quantification is based 
on peak area corrected for the internal standard. 
 
)LJXUH0HDVXUHGFRQFHQWUDWLRQRIމ-methoxy-މ-hydroxy-phenylpropionic acid (DHFA) in 
SODVPDDIWHUFRQVXPSWLRQRIRQHFXSRIFRIIHHƔRUFDOFXODWHGDIWHUVHYHQFXSVRQHHYHry 
PLQŶ'DWDRQVLQJOHGRVHWDNHQIURP[20] and is the DHFA plasma concentration 
after consumption of a cup of coffee (3.4 g of instant coffee in 200 ml water) containing 412 
mg total chlorogenic acid. Effect of seven doses consumed every 120 min was calculated 
using simple addition of each time point from the single dose data, without taking into 
account any change in plasma clearance as a function of plasma concentration.  
 
Figure 8: Possible catabolic routes from hesperetin to hydroxyphenylhydracrylic acids. 
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Table 1: Comparison of plasma and colon catabolite concentrations in volunteers 
compared to concentrations shown to be effective in in vitro  
Catabolite Plasma 
Cmax 
concentra
tion 
Faecal 
water  
[171] or 
faeces 
concentra
tion [175] 
Concentra
tion range 
used 
Tissue Minimum 
effective 
concentra
tion 
IC
50 
Biomark
er 
Refere
nce 
Protocatech
uic acid 
 
 
 
0.17 µM 
[22] 
mean 
0.16 µM, 
range 
0.02±0.64 
µM [176] 
 
 
 
0.32±1.41 
µM [171] 
0.28 ± 
0.54 
µmol/g 
[175] 
0±100 
µM 
LPS-
stimulate
d 
macroph
ages 
10 µM   Suppres
sion of 
NO 
[177] 
Protocatech
uic acid 
 Human 
prostate 
cancer 
cells  
 43 
µ
M 
Eph 
tyrosine 
kinase 
receptor
s 
[178] 
Protocatech
uic acid 
 TNF-Į-
stimulate
d 
HUVECs
. 
1 µM  VCAM-
1 protein 
secretio
n 
[173] 
Protocatech
uic acid 
0±10 µM Oxidativ
ely 
challenge
d 
HUVECs 
0.1 µM  IL6 
producti
on 
[179] 
Protocatech
uic acid 
 HUVECs 0.2 µM  monocyt
e 
adhesion 
to 
TNFD-
stimulat
ed 
HUVEC 
[180] 
Protocatech
uic acid-ƍ-
O--sulfate 
  0±10 µM Oxidativ
ely 
challenge
d 
HUVECs 
0.1 µM  IL6 
producti
on 
[179] 
Protocatech
uic acid-ƍ-
O-sulfate 
   TNF-Į-
stimulate
d 
HUVECs
. 
1 µM  VCAM-
1 protein 
secretio
n 
[173] 
Protocatech
uic acid-ƍ-
O-sulfate 
   TNF-Į-
stimulate
d 
HUVECs
. 
1 µM  VCAM-
1 protein 
secretio
n 
[173] 
Vanillic Mean 0.11±1.24 0±10 µM Oxidativ 0.1 µM  IL6 [179] 
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acid 0.02 µM, 
range 
0.006±
0.08 µM 
[176] 
µM ely 
challenge
d 
HUVECs 
producti
on 
Gallic acid 1.2 ± 1.0 
µM [82] 
0.17±1.40 
µM 
 Human 
prostate 
cancer 
cells  
 0.2
6 
µ
M 
Eph 
tyrosine 
kinase 
receptor
s 
[178] 
ƍƍ-
Dihydroxy-
phenylaceti
c acid 
 0.47±
16.43 µM 
 Human 
prostate 
cancer 
cells  
 13 
µ
M 
Eph 
tyrosine 
kinase 
receptor
s 
[178] 
ƍƍ-
Dihydroxy-
phenylaceti
c acid  
  0±10 µM  Pancreati
Fȕ-cells 
1 µM  Insulin 
secretio
n 
[181] 
މ-hydroxy-
phenylprop
ionic acid 
 6.9±43.7 
µmol/g 
[175] 
0±10 µM  Pancreati
Fȕ-cells 
1 µM  Insulin 
secretio
n 
[181] 
މމ-
dihydroxy-
phenylprop
ionic acid 
(DHCA) 
49±72 
nM [167]  
41 ± 10 
nM [20] 
0.67±9.42 
µM 
0.2±10 
µM 
t-BOOH-
stimulate
d HepG2 
cells  
1 µM  GSH 
content 
[182] 
މ-methoxy-
މ-hydroxy-
phenylprop
ionic acid 
(DHFA) 
385 ± 86 
nM [20] 
0.88 ± 
0.64 µM 
[168]a 
 0.2±10 
µM 
t-BOOH-
stimulate
d HepG2 
cells  
0.2 µM  GSH 
content 
[182] 
 
Notes:  a: Dose given equivalent to ca two cups of coffee. HUVEC, human umbilical cord 
endothelial cell  
 
